Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

GAUDIO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 179
EU - Europa 54
AS - Asia 42
OC - Oceania 1
Totale 276
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 176
SG - Singapore 37
IT - Italia 24
DE - Germania 16
CN - Cina 5
FI - Finlandia 4
BE - Belgio 3
BZ - Belize 2
NL - Olanda 2
AU - Australia 1
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
FR - Francia 1
PL - Polonia 1
UA - Ucraina 1
Totale 276
Salva come PNG Salva come JPEG
Città #
Chandler 61
Singapore 26
Boardman 17
Bari 10
Munich 10
Lawrence 9
Princeton 9
Atlanta 8
Bitonto 3
Brussels 3
Helsinki 3
Mammelzen 3
Ashburn 2
Las Vegas 2
Milan 2
Belize City 1
Brno 1
Buffalo 1
Clearwater 1
Dongyang 1
Eichenau 1
Espoo 1
Guiyang 1
Hanover 1
Jinan 1
Kaifeng 1
Miami 1
Nuremberg 1
San Mateo 1
Santa Clara 1
Toronto 1
Totale 184
Salva come PNG Salva come JPEG
Nome #
The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells 29
STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas 26
STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas 26
Tumor cell microenvironment and microvessel density analysis in MALT type lymphoma 25
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 22
Different spatial distribution of inflammatory cells in the tumor microenvironment of ABC and GBC subgroups of diffuse large B cell lymphoma 22
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 21
Tumor Microenvironment and Microvascular Density in Follicular Lymphoma 19
Inflammatory Cells in Diffuse Large B Cell Lymphoma 14
Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma 12
T cells, mast cells and microvascular density in diffuse large B cell lymphoma 7
Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview 6
Bone Involvement in Hodgkin's Lymphoma: Clinical Features and Outcome 6
Molecular Features and Diagnostic Challenges in Alpha/Beta T-Cell Large Granular Lymphocyte Leukemia 6
Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP) 6
Different patterns of mast cell distribution in B-cell non-Hodgkin lymphomas 4
Extralymphatic Disease Is an Independent Prognostic Factor in Hodgkin Lymphoma 4
Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma 4
Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma 4
Pregnancy rate and outcome of pregnancies in long-term survivors of Hodgkin's lymphoma 3
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience 3
Computer-driven quantitative image analysis in the assessment of tumor cell and T cell features in diffuse large B cell lymphomas 3
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis 3
Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AML 3
Computed tomography-guided needle biopsy performed with modified coaxial technique in patients with suspected lymphoma 3
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma 3
CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation 3
CT-guided needle biopsy performed with modified coaxial technique in patients with refractory or recurrent lymphomas 3
Long-term Hodgkin Lymphoma Survivors: A Glimpse of What Happens 10 Years After Treatment 3
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice 3
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients 3
Outcomes of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphomas: A Retrospective Multicenter Experience by the Rete Ematologica Pugliese (REP) 2
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program 2
Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin's lymphoma patients 2
Peripheral blood CD4/CD19 cell ratio is an independent prognostic factor in classical Hodgkin lymphoma 2
Microvascular density, CD68 and tryptase expression in human diffuse large B-cell lymphoma 2
The Tumor Microenvironment in Classic Hodgkin's Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy 2
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 2
Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas 2
STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas 2
CT-guided needle biopsy performed with modified coaxial technique in the diagnosis of malignant lymphomas 2
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma 2
High Ki67 index and bulky disease remain significant adverse prognostic factors in patients with diffuse large B cell lymphoma before and after the introduction of rituximab 2
Recovery of CMV-specific CD8(+) T cells and T regs after allogeneic peripheral blood stem cell transplantation 2
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience 2
Relapsing/refractory HL After Autotransplantation: Which Treatment? 2
Risk of lymphoma subtypes by occupational exposure in southern Italy 1
Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation 1
Totale 331
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.488
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 0 0 0 0 0 0 7 0 8 10 1 1
2022/2023134 18 0 0 24 13 24 0 10 30 1 14 0
2023/2024107 5 4 2 3 5 1 2 2 8 49 5 21
2024/202563 6 20 17 19 1 0 0 0 0 0 0 0
Totale 331